Mitigating adverse immune reactions involves modifying the physical and chemical properties of the catalytic materials to make them less recognizable by the immune system. This can include surface modifications, such as coating with biocompatible materials, reducing the size of nanoparticles, or utilizing biodegradable catalysts. Developing a thorough understanding of the interaction between the catalyst and the immune system is crucial for designing safer catalytic systems.
